The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ISHARES MSCI BRAZIL ETF | ETP | 464286400 | 19,100 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
GENERAL ELECTRIC CO | Common Stock | 369604103 | 12,112 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
OI SA-ADR | ADR | 670851500 | 4,524 | 2,827,201 | SH | SOLE | 2,827,201 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | Common Stock | 91324P102 | 1,468 | 5,893 | SH | SOLE | 5,893 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common Stock | 09061G101 | 1,047 | 12,292 | SH | SOLE | 12,292 | 0 | 0 | ||
INCYTE CORP | Common Stock | 45337C102 | 949 | 14,916 | SH | SOLE | 14,916 | 0 | 0 | ||
SEATTLE GENETICS INC | Common Stock | 812578102 | 936 | 16,524 | SH | SOLE | 16,524 | 0 | 0 | ||
ILLUMINA INC | Common Stock | 452327109 | 875 | 2,917 | SH | SOLE | 2,917 | 0 | 0 | ||
PAGSEGURO DIGITAL LTD-CL A | Common Stock | G68707101 | 805 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | Common Stock | 803607100 | 782 | 7,166 | SH | SOLE | 7,166 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | Common Stock | 015351109 | 628 | 6,449 | SH | SOLE | 6,449 | 0 | 0 | ||
HUMANA INC | Common Stock | 444859102 | 586 | 2,044 | SH | SOLE | 2,044 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | Common Stock | 110122108 | 546 | 10,496 | SH | SOLE | 10,496 | 0 | 0 | ||
CIGNA CORP | Common Stock | 125523100 | 541 | 2,850 | SH | SOLE | 2,850 | 0 | 0 | ||
BEIGENE LTD-ADR | ADR | 07725L102 | 527 | 3,757 | SH | SOLE | 3,757 | 0 | 0 | ||
CENTENE CORP | Common Stock | 15135B101 | 480 | 4,160 | SH | SOLE | 4,160 | 0 | 0 | ||
SAGE THERAPEUTICS INC | Common Stock | 78667J108 | 477 | 4,983 | SH | SOLE | 4,983 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | Common Stock | 101137107 | 434 | 12,271 | SH | SOLE | 12,271 | 0 | 0 | ||
ABBOTT LABORATORIES | Common Stock | 002824100 | 418 | 5,781 | SH | SOLE | 5,781 | 0 | 0 | ||
DEXCOM INC | Common Stock | 252131107 | 411 | 3,433 | SH | SOLE | 3,433 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | Common Stock | 92532F100 | 372 | 2,245 | SH | SOLE | 2,245 | 0 | 0 | ||
EXACT SCIENCES CORP | Common Stock | 30063P105 | 370 | 5,863 | SH | SOLE | 5,863 | 0 | 0 | ||
MERCK & CO. INC. | Common Stock | 58933Y105 | 360 | 4,716 | SH | SOLE | 4,716 | 0 | 0 | ||
EXELIXIS INC | Common Stock | 30161Q104 | 339 | 17,215 | SH | SOLE | 17,215 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | Common Stock | 28176E108 | 338 | 2,208 | SH | SOLE | 2,208 | 0 | 0 | ||
ALLERGAN PLC | Common Stock | G0177J108 | 330 | 2,466 | SH | SOLE | 2,466 | 0 | 0 | ||
BLUEBIRD BIO INC | Common Stock | 09609G100 | 325 | 3,281 | SH | SOLE | 3,281 | 0 | 0 | ||
ABBVIE INC | Common Stock | 00287Y109 | 318 | 3,454 | SH | SOLE | 3,454 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | Common Stock | 045396108 | 314 | 13,897 | SH | SOLE | 13,897 | 0 | 0 | ||
ANTHEM INC | Common Stock | 036752103 | 309 | 1,177 | SH | SOLE | 1,177 | 0 | 0 | ||
ELI LILLY & CO | Common Stock | 532457108 | 304 | 2,631 | SH | SOLE | 2,631 | 0 | 0 | ||
CELGENE CORP | Common Stock | 151020104 | 292 | 4,551 | SH | SOLE | 4,551 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common Stock | 03152W109 | 290 | 30,287 | SH | SOLE | 30,287 | 0 | 0 | ||
GENOMIC HEALTH INC | Common Stock | 37244C101 | 286 | 4,438 | SH | SOLE | 4,438 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | Common Stock | 00771V108 | 279 | 7,723 | SH | SOLE | 7,723 | 0 | 0 | ||
BIOGEN INC | Common Stock | 09062X103 | 257 | 855 | SH | SOLE | 855 | 0 | 0 | ||
GW PHARMACEUTICALS -ADR | ADR | 36197T103 | 242 | 2,480 | SH | SOLE | 2,480 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | Common Stock | 37890U108 | 237 | 5,764 | SH | SOLE | 5,764 | 0 | 0 | ||
PROQR THERAPEUTICS NV | Common Stock | N71542109 | 235 | 14,870 | SH | SOLE | 14,870 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | Common Stock | 64125C109 | 214 | 2,997 | SH | SOLE | 2,997 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | Common Stock | 75886F107 | 205 | 548 | SH | SOLE | 548 | 0 | 0 | ||
ARGENX SE - ADR | ADR | 04016X101 | 202 | 2,100 | SH | SOLE | 2,100 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common Stock | 09058V103 | 191 | 23,724 | SH | SOLE | 23,724 | 0 | 0 | ||
NATERA INC | Common Stock | 632307104 | 171 | 12,238 | SH | SOLE | 12,238 | 0 | 0 | ||
IMMUNOMEDICS INC | Common Stock | 452907108 | 169 | 11,855 | SH | SOLE | 11,855 | 0 | 0 | ||
AMARIN CORP PLC -ADR | ADR | 023111206 | 150 | 11,024 | SH | SOLE | 11,024 | 0 | 0 | ||
EPIZYME INC | Common Stock | 29428V104 | 76 | 12,398 | SH | SOLE | 12,398 | 0 | 0 | ||
DBV TECHNOLOGIES SA-SPON ADR | ADR | 23306J101 | 66 | 10,213 | SH | SOLE | 10,213 | 0 | 0 | ||
PROTEOSTASIS THERAPEUTICS IN | Common Stock | 74373B109 | 64 | 19,790 | SH | SOLE | 19,790 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | Common Stock | 67576A100 | 50 | 12,568 | SH | SOLE | 12,568 | 0 | 0 | ||
OI SA-ADR | ADR | 670851401 | 7 | 28,567 | SH | SOLE | 28,567 | 0 | 0 | ||
ISHARES MSCI EMERGING MARKET | ETP | 464287234 | 1,953 | 50,000 | SH | Call | SOLE | 500 | 0 | 0 | |
ISHARES MSCI BRAZIL ETF | ETP | 464286400 | 382 | 10,000 | SH | Put | SOLE | 100 | 0 | 0 | |
KRAFT HEINZ CO/THE | Common Stock | 500754106 | 23,672 | 550,000 | SH | Put | SOLE | 5,500 | 0 | 0 | |
SPDR S&P OIL & GAS EXP & PR | ETP | 78464A730 | 1,327 | 50,000 | SH | Call | SOLE | 500 | 0 | 0 |